Verogen is a gene sequencing service provider. The company is committed to tailoring next-generation gene sequencing solutions for forensic laboratories, and is mainly committed to commercializing Illumina’s sequencing technology in criminal investigation. Recently, QIAGEN announced that it has completed the acquisition of Verogen to strengthen the company’s future leading position in the field of human identification and forensics. FPS will pay $150 million in cash to complete the acquisition.
This article is transferred from: https://www.itjuzi.com/merger/9620
This site is only for collection, and the copyright belongs to the original author.